Phoreus Biotechnology, Inc.
PrivateLast Round
Seed Round
Mar 13, 2026
Total Funding Raised
$3.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Phoreus Biotechnology, Inc. is a biotechnology company that provides proprietary nanocarrier platforms for the delivery of vaccines, cancer therapies, alternative antibiotics, and biopesticides.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phoreus Biotechnology, Inc. Comparables
Compare Phoreus Biotechnology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Entos Pharmaceuticals | 84% | |
| Ligandal, Inc. | 82% | |
| Genevant Sciences | 80% | |
Phoreus Biotechnology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 13, 2026 | ||||
| Seed | Dec 20, 2022 | ||||
| Angel | Dec 30, 2019 | ||||
| Seed | Jul 30, 2019 |
Key People
Founding team and executive leadership
Phoreus Biotechnology, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Digital Sandbox KC | Seed |
| Fountain Innovation Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2026
$421K seed round completed.
- Dec 30, 2019
$550K raised in an angel round.
Phoreus Biotechnology, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phoreus Biotechnology, Inc.'s valuation, stock price, and market status.